EUDA Health (NASDAQ:EUDA) Price Target Cut to $2.75 by Analysts at Greenridge Global

EUDA Health (NASDAQ:EUDA) had its target price trimmed by Greenridge Global from $6.00 to $2.75 in a report issued on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $2.75.

EUDA Health Stock Performance

Shares of NASDAQ EUDA opened at $0.49 on Monday. The stock has a market cap of $18.53 million, a PE ratio of -4.08 and a beta of -0.11. The business has a fifty day moving average of $1.40 and a two-hundred day moving average of $2.03. EUDA Health has a 52-week low of $0.46 and a 52-week high of $4.30.

Hedge Funds Weigh In On EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC acquired a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health as of its most recent filing with the SEC. Hedge funds and other institutional investors own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.